nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—bone cancer—salivary gland cancer	0.48	0.531	CtDrD
Methotrexate—muscle cancer—salivary gland cancer	0.424	0.469	CtDrD
Methotrexate—SLC19A1—tongue—salivary gland cancer	0.00451	0.0943	CbGeAlD
Methotrexate—FOLR1—parotid gland—salivary gland cancer	0.00241	0.0504	CbGeAlD
Methotrexate—FOLR1—saliva-secreting gland—salivary gland cancer	0.00231	0.0482	CbGeAlD
Methotrexate—FOLR1—epithelium—salivary gland cancer	0.00201	0.0421	CbGeAlD
Methotrexate—GGH—parotid gland—salivary gland cancer	0.0016	0.0335	CbGeAlD
Methotrexate—FOLR1—lymphoid tissue—salivary gland cancer	0.00155	0.0324	CbGeAlD
Methotrexate—GGH—saliva-secreting gland—salivary gland cancer	0.00153	0.0321	CbGeAlD
Methotrexate—SLCO4C1—parotid gland—salivary gland cancer	0.00142	0.0297	CbGeAlD
Methotrexate—SLC19A1—lymphoid tissue—salivary gland cancer	0.00136	0.0284	CbGeAlD
Methotrexate—FPGS—saliva-secreting gland—salivary gland cancer	0.00135	0.0282	CbGeAlD
Methotrexate—MTHFR—neck—salivary gland cancer	0.00124	0.026	CbGeAlD
Methotrexate—FPGS—connective tissue—salivary gland cancer	0.00124	0.0259	CbGeAlD
Methotrexate—ATIC—connective tissue—salivary gland cancer	0.0012	0.025	CbGeAlD
Methotrexate—ATIC—epithelium—salivary gland cancer	0.00114	0.0238	CbGeAlD
Methotrexate—PGD—neck—salivary gland cancer	0.00108	0.0226	CbGeAlD
Methotrexate—SLC46A1—lymphoid tissue—salivary gland cancer	0.00105	0.0219	CbGeAlD
Methotrexate—FPGS—lymphoid tissue—salivary gland cancer	0.000906	0.0189	CbGeAlD
Methotrexate—PGD—parotid gland—salivary gland cancer	0.000879	0.0184	CbGeAlD
Methotrexate—ATIC—lymphoid tissue—salivary gland cancer	0.000876	0.0183	CbGeAlD
Methotrexate—DHFR—saliva-secreting gland—salivary gland cancer	0.000876	0.0183	CbGeAlD
Methotrexate—PGD—saliva-secreting gland—salivary gland cancer	0.000842	0.0176	CbGeAlD
Methotrexate—TYMS—connective tissue—salivary gland cancer	0.000813	0.017	CbGeAlD
Methotrexate—DHFR—connective tissue—salivary gland cancer	0.000805	0.0168	CbGeAlD
Methotrexate—PGD—connective tissue—salivary gland cancer	0.000774	0.0162	CbGeAlD
Methotrexate—SLC19A1—lymph node—salivary gland cancer	0.000767	0.016	CbGeAlD
Methotrexate—ABCC10—parotid gland—salivary gland cancer	0.000754	0.0158	CbGeAlD
Methotrexate—ABCC10—saliva-secreting gland—salivary gland cancer	0.000722	0.0151	CbGeAlD
Methotrexate—SLC16A1—epithelium—salivary gland cancer	0.000686	0.0143	CbGeAlD
Methotrexate—MTHFR—lymphoid tissue—salivary gland cancer	0.000651	0.0136	CbGeAlD
Methotrexate—TYMS—lymphoid tissue—salivary gland cancer	0.000594	0.0124	CbGeAlD
Methotrexate—SLC46A1—lymph node—salivary gland cancer	0.000591	0.0124	CbGeAlD
Methotrexate—DHFR—lymphoid tissue—salivary gland cancer	0.000588	0.0123	CbGeAlD
Methotrexate—GGH—lymph node—salivary gland cancer	0.000581	0.0122	CbGeAlD
Methotrexate—PGD—lymphoid tissue—salivary gland cancer	0.000566	0.0118	CbGeAlD
Methotrexate—ABCC1—parotid gland—salivary gland cancer	0.000533	0.0111	CbGeAlD
Methotrexate—FPGS—lymph node—salivary gland cancer	0.000511	0.0107	CbGeAlD
Methotrexate—ATIC—lymph node—salivary gland cancer	0.000494	0.0103	CbGeAlD
Methotrexate—ABCC10—lymphoid tissue—salivary gland cancer	0.000485	0.0101	CbGeAlD
Methotrexate—ABCG2—parotid gland—salivary gland cancer	0.000441	0.00922	CbGeAlD
Methotrexate—ABCG2—saliva-secreting gland—salivary gland cancer	0.000423	0.00883	CbGeAlD
Methotrexate—SLCO1C1—lymph node—salivary gland cancer	0.000411	0.00859	CbGeAlD
Methotrexate—MTHFR—lymph node—salivary gland cancer	0.000367	0.00768	CbGeAlD
Methotrexate—SLCO3A1—lymph node—salivary gland cancer	0.000362	0.00756	CbGeAlD
Methotrexate—TYMS—lymph node—salivary gland cancer	0.000335	0.00701	CbGeAlD
Methotrexate—DHFR—lymph node—salivary gland cancer	0.000332	0.00694	CbGeAlD
Methotrexate—PGD—lymph node—salivary gland cancer	0.000319	0.00667	CbGeAlD
Methotrexate—SLC16A1—lymph node—salivary gland cancer	0.000298	0.00623	CbGeAlD
Methotrexate—AOX1—lymph node—salivary gland cancer	0.000281	0.00588	CbGeAlD
Methotrexate—ABCC3—lymph node—salivary gland cancer	0.000275	0.00575	CbGeAlD
Methotrexate—ABCC10—lymph node—salivary gland cancer	0.000274	0.00572	CbGeAlD
Methotrexate—ALB—lymph node—salivary gland cancer	0.000235	0.0049	CbGeAlD
Methotrexate—ABCC4—lymph node—salivary gland cancer	0.000227	0.00474	CbGeAlD
Methotrexate—ABCC2—lymph node—salivary gland cancer	0.00022	0.00459	CbGeAlD
Methotrexate—ABCC1—lymph node—salivary gland cancer	0.000194	0.00405	CbGeAlD
Methotrexate—ABCB1—epithelium—salivary gland cancer	0.000182	0.0038	CbGeAlD
Methotrexate—ABCG2—lymph node—salivary gland cancer	0.00016	0.00335	CbGeAlD
Methotrexate—ABCB1—lymphoid tissue—salivary gland cancer	0.00014	0.00293	CbGeAlD
Methotrexate—ABCB1—lymph node—salivary gland cancer	7.9e-05	0.00165	CbGeAlD
Methotrexate—SLC19A1—Disease—EP300—salivary gland cancer	2.46e-05	0.000507	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	2.45e-05	0.000506	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PYGB—salivary gland cancer	2.44e-05	0.000503	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ST3GAL4—salivary gland cancer	2.42e-05	0.000498	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NUP62—salivary gland cancer	2.41e-05	0.000498	CbGpPWpGaD
Methotrexate—PGD—Disease—NOTCH1—salivary gland cancer	2.41e-05	0.000497	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—CREBBP—salivary gland cancer	2.41e-05	0.000497	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—VCAN—salivary gland cancer	2.4e-05	0.000494	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CREBBP—salivary gland cancer	2.39e-05	0.000493	CbGpPWpGaD
Methotrexate—MTHFR—Disease—FOXO3—salivary gland cancer	2.38e-05	0.00049	CbGpPWpGaD
Methotrexate—ABCC1—Disease—DTX4—salivary gland cancer	2.36e-05	0.000486	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—TP53—salivary gland cancer	2.36e-05	0.000486	CbGpPWpGaD
Methotrexate—AOX1—Disease—FOXO3—salivary gland cancer	2.32e-05	0.000479	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—AQP1—salivary gland cancer	2.29e-05	0.000472	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PHGDH—salivary gland cancer	2.26e-05	0.000466	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NUP62—salivary gland cancer	2.21e-05	0.000457	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—MYB—salivary gland cancer	2.21e-05	0.000455	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—VCAN—salivary gland cancer	2.2e-05	0.000453	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—AQP1—salivary gland cancer	2.19e-05	0.000453	CbGpPWpGaD
Methotrexate—FPGS—Disease—PTEN—salivary gland cancer	2.19e-05	0.000452	CbGpPWpGaD
Methotrexate—PGD—Disease—CREBBP—salivary gland cancer	2.19e-05	0.000451	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ST3GAL4—salivary gland cancer	2.17e-05	0.000449	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—PTEN—salivary gland cancer	2.16e-05	0.000445	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PHGDH—salivary gland cancer	2.15e-05	0.000443	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	2.13e-05	0.000439	CbGpPWpGaD
Methotrexate—DHFR—Disease—FOXO3—salivary gland cancer	2.11e-05	0.000436	CbGpPWpGaD
Methotrexate—FPGS—Disease—EP300—salivary gland cancer	2.09e-05	0.000431	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	2.09e-05	0.00043	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ST3GAL4—salivary gland cancer	2.07e-05	0.000426	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—CCND1—salivary gland cancer	2.07e-05	0.000426	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—EP300—salivary gland cancer	2.06e-05	0.000424	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TP53—salivary gland cancer	2.02e-05	0.000417	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	2.01e-05	0.000414	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—CREBBP—salivary gland cancer	2e-05	0.000413	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NUP62—salivary gland cancer	2e-05	0.000412	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PHGDH—salivary gland cancer	1.99e-05	0.00041	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ISYNA1—salivary gland cancer	1.99e-05	0.00041	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—VCAN—salivary gland cancer	1.98e-05	0.000409	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—AQP1—salivary gland cancer	1.97e-05	0.000407	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGF16—salivary gland cancer	1.95e-05	0.000402	CbGpPWpGaD
Methotrexate—MTHFR—Disease—MAP2K2—salivary gland cancer	1.94e-05	0.0004	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.93e-05	0.000398	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.93e-05	0.000398	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ST3GAL4—salivary gland cancer	1.91e-05	0.000395	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—EP300—salivary gland cancer	1.9e-05	0.000392	CbGpPWpGaD
Methotrexate—AOX1—Disease—MAP2K2—salivary gland cancer	1.9e-05	0.000391	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—AQP1—salivary gland cancer	1.88e-05	0.000387	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NUP62—salivary gland cancer	1.87e-05	0.000386	CbGpPWpGaD
Methotrexate—ABCC1—Disease—VCAN—salivary gland cancer	1.85e-05	0.000383	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—CCND1—salivary gland cancer	1.85e-05	0.000381	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—PTEN—salivary gland cancer	1.83e-05	0.000378	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—PTEN—salivary gland cancer	1.83e-05	0.000378	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.83e-05	0.000378	CbGpPWpGaD
Methotrexate—PGD—Metabolism—CREBBP—salivary gland cancer	1.83e-05	0.000377	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—PIK3CA—salivary gland cancer	1.82e-05	0.000375	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—NUP62—salivary gland cancer	1.82e-05	0.000374	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—CCND1—salivary gland cancer	1.8e-05	0.000372	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—CREBBP—salivary gland cancer	1.8e-05	0.000371	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	1.79e-05	0.000369	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	1.76e-05	0.000362	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—EP300—salivary gland cancer	1.75e-05	0.000361	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—EP300—salivary gland cancer	1.75e-05	0.000361	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NUP62—salivary gland cancer	1.74e-05	0.000359	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.74e-05	0.000359	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ISYNA1—salivary gland cancer	1.74e-05	0.000359	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—AQP1—salivary gland cancer	1.74e-05	0.000358	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—VCAN—salivary gland cancer	1.73e-05	0.000356	CbGpPWpGaD
Methotrexate—DHFR—Disease—MAP2K2—salivary gland cancer	1.72e-05	0.000356	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—PTEN—salivary gland cancer	1.71e-05	0.000352	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—EP300—salivary gland cancer	1.7e-05	0.000351	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MAML2—salivary gland cancer	1.69e-05	0.000349	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—HRAS—salivary gland cancer	1.68e-05	0.000347	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—EP300—salivary gland cancer	1.66e-05	0.000342	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.65e-05	0.000341	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—EP300—salivary gland cancer	1.64e-05	0.000339	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—EP300—salivary gland cancer	1.63e-05	0.000336	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.62e-05	0.000335	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MARCKS—salivary gland cancer	1.62e-05	0.000334	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—CCND1—salivary gland cancer	1.61e-05	0.000333	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	1.59e-05	0.000328	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOTCH1—salivary gland cancer	1.59e-05	0.000328	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NUP62—salivary gland cancer	1.57e-05	0.000323	CbGpPWpGaD
Methotrexate—PGD—Disease—PTEN—salivary gland cancer	1.56e-05	0.000322	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.56e-05	0.000321	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—VCAN—salivary gland cancer	1.55e-05	0.00032	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	1.55e-05	0.00032	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOTCH1—salivary gland cancer	1.55e-05	0.00032	CbGpPWpGaD
Methotrexate—FPGS—Disease—PIK3CA—salivary gland cancer	1.54e-05	0.000319	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—PIK3CA—salivary gland cancer	1.52e-05	0.000314	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.52e-05	0.000313	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PYGB—salivary gland cancer	1.5e-05	0.00031	CbGpPWpGaD
Methotrexate—PGD—Disease—EP300—salivary gland cancer	1.49e-05	0.000307	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NUP62—salivary gland cancer	1.49e-05	0.000307	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—EP300—salivary gland cancer	1.48e-05	0.000306	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—VCAN—salivary gland cancer	1.48e-05	0.000305	CbGpPWpGaD
Methotrexate—ABCC1—Disease—JAG1—salivary gland cancer	1.45e-05	0.000298	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CREBBP—salivary gland cancer	1.44e-05	0.000297	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.44e-05	0.000297	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGFR4—salivary gland cancer	1.44e-05	0.000297	CbGpPWpGaD
Methotrexate—FPGS—Disease—HRAS—salivary gland cancer	1.43e-05	0.000295	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PTEN—salivary gland cancer	1.43e-05	0.000295	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MARCKS—salivary gland cancer	1.42e-05	0.000293	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FBXW7—salivary gland cancer	1.42e-05	0.000292	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOTCH1—salivary gland cancer	1.41e-05	0.000291	CbGpPWpGaD
Methotrexate—AOX1—Disease—CREBBP—salivary gland cancer	1.41e-05	0.00029	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NUP62—salivary gland cancer	1.38e-05	0.000284	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	1.38e-05	0.000284	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—VCAN—salivary gland cancer	1.37e-05	0.000282	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.36e-05	0.000281	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—EP300—salivary gland cancer	1.36e-05	0.000281	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.35e-05	0.000279	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PYGB—salivary gland cancer	1.32e-05	0.000272	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	1.31e-05	0.000271	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.31e-05	0.000271	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PTEN—salivary gland cancer	1.31e-05	0.00027	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.3e-05	0.000267	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.3e-05	0.000267	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—PIK3CA—salivary gland cancer	1.29e-05	0.000267	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—PIK3CA—salivary gland cancer	1.29e-05	0.000267	CbGpPWpGaD
Methotrexate—DHFR—Disease—CREBBP—salivary gland cancer	1.28e-05	0.000264	CbGpPWpGaD
Methotrexate—PGD—Metabolism—EP300—salivary gland cancer	1.25e-05	0.000257	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	1.24e-05	0.000256	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.23e-05	0.000254	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PHGDH—salivary gland cancer	1.23e-05	0.000253	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—EP300—salivary gland cancer	1.22e-05	0.000252	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—TP53—salivary gland cancer	1.22e-05	0.000251	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—PIK3CA—salivary gland cancer	1.21e-05	0.00025	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CREBBP—salivary gland cancer	1.21e-05	0.000249	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—PIK3CA—salivary gland cancer	1.2e-05	0.000248	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FOXO3—salivary gland cancer	1.2e-05	0.000247	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	1.18e-05	0.000244	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ST3GAL4—salivary gland cancer	1.18e-05	0.000244	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CREBBP—salivary gland cancer	1.18e-05	0.000243	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TP53—salivary gland cancer	1.17e-05	0.000242	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	1.15e-05	0.000237	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.14e-05	0.000235	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—HRAS—salivary gland cancer	1.12e-05	0.000232	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—HRAS—salivary gland cancer	1.11e-05	0.00023	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	1.11e-05	0.000229	CbGpPWpGaD
Methotrexate—PGD—Disease—PIK3CA—salivary gland cancer	1.1e-05	0.000227	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	1.08e-05	0.000223	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PHGDH—salivary gland cancer	1.07e-05	0.000222	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CREBBP—salivary gland cancer	1.07e-05	0.000221	CbGpPWpGaD
Methotrexate—ALB—Metabolism—AQP1—salivary gland cancer	1.07e-05	0.000221	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—TP53—salivary gland cancer	1.06e-05	0.000219	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	1.06e-05	0.000218	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	1.03e-05	0.000213	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	1.03e-05	0.000213	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PTEN—salivary gland cancer	1.03e-05	0.000212	CbGpPWpGaD
Methotrexate—PGD—Disease—HRAS—salivary gland cancer	1.02e-05	0.00021	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PIK3CA—salivary gland cancer	1.01e-05	0.000208	CbGpPWpGaD
Methotrexate—AOX1—Disease—PTEN—salivary gland cancer	1.01e-05	0.000207	CbGpPWpGaD
Methotrexate—MTHFR—Disease—EP300—salivary gland cancer	9.82e-06	0.000203	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CREBBP—salivary gland cancer	9.77e-06	0.000202	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MAP2K2—salivary gland cancer	9.76e-06	0.000201	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	9.74e-06	0.000201	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	9.71e-06	0.0002	CbGpPWpGaD
Methotrexate—AOX1—Disease—EP300—salivary gland cancer	9.59e-06	0.000198	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—AQP1—salivary gland cancer	9.39e-06	0.000194	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CREBBP—salivary gland cancer	9.36e-06	0.000193	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	9.28e-06	0.000192	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	9.25e-06	0.000191	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PIK3CA—salivary gland cancer	9.22e-06	0.00019	CbGpPWpGaD
Methotrexate—DHFR—Disease—PTEN—salivary gland cancer	9.15e-06	0.000189	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—PIK3CA—salivary gland cancer	9.05e-06	0.000187	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	8.82e-06	0.000182	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	8.77e-06	0.000181	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TP53—salivary gland cancer	8.76e-06	0.000181	CbGpPWpGaD
Methotrexate—DHFR—Disease—EP300—salivary gland cancer	8.72e-06	0.00018	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PTEN—salivary gland cancer	8.62e-06	0.000178	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CREBBP—salivary gland cancer	8.59e-06	0.000177	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NUP62—salivary gland cancer	8.5e-06	0.000175	CbGpPWpGaD
Methotrexate—ALB—Metabolism—VCAN—salivary gland cancer	8.43e-06	0.000174	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PTEN—salivary gland cancer	8.42e-06	0.000174	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—HRAS—salivary gland cancer	8.38e-06	0.000173	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—EP300—salivary gland cancer	8.22e-06	0.00017	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—CREBBP—salivary gland cancer	8.13e-06	0.000168	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—EP300—salivary gland cancer	8.03e-06	0.000166	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOTCH1—salivary gland cancer	8e-06	0.000165	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	7.95e-06	0.000164	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	7.83e-06	0.000161	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CREBBP—salivary gland cancer	7.75e-06	0.00016	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTEN—salivary gland cancer	7.66e-06	0.000158	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	7.63e-06	0.000157	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	7.57e-06	0.000156	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NUP62—salivary gland cancer	7.45e-06	0.000154	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	7.4e-06	0.000153	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—VCAN—salivary gland cancer	7.39e-06	0.000152	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—EP300—salivary gland cancer	7.31e-06	0.000151	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PIK3CA—salivary gland cancer	7.26e-06	0.00015	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CREBBP—salivary gland cancer	7.25e-06	0.00015	CbGpPWpGaD
Methotrexate—AOX1—Disease—PIK3CA—salivary gland cancer	7.09e-06	0.000146	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	7.04e-06	0.000145	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTEN—salivary gland cancer	6.98e-06	0.000144	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	6.87e-06	0.000142	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CREBBP—salivary gland cancer	6.75e-06	0.000139	CbGpPWpGaD
Methotrexate—MTHFR—Disease—HRAS—salivary gland cancer	6.72e-06	0.000139	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTEN—salivary gland cancer	6.69e-06	0.000138	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—EP300—salivary gland cancer	6.65e-06	0.000137	CbGpPWpGaD
Methotrexate—AOX1—Disease—HRAS—salivary gland cancer	6.56e-06	0.000135	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	6.53e-06	0.000135	CbGpPWpGaD
Methotrexate—DHFR—Disease—PIK3CA—salivary gland cancer	6.45e-06	0.000133	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—EP300—salivary gland cancer	6.38e-06	0.000132	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	6.17e-06	0.000127	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTEN—salivary gland cancer	6.13e-06	0.000127	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PIK3CA—salivary gland cancer	6.08e-06	0.000125	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CREBBP—salivary gland cancer	6.07e-06	0.000125	CbGpPWpGaD
Methotrexate—DHFR—Disease—HRAS—salivary gland cancer	5.97e-06	0.000123	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PIK3CA—salivary gland cancer	5.94e-06	0.000123	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—EP300—salivary gland cancer	5.85e-06	0.000121	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CREBBP—salivary gland cancer	5.77e-06	0.000119	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—EP300—salivary gland cancer	5.54e-06	0.000114	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTEN—salivary gland cancer	5.53e-06	0.000114	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PIK3CA—salivary gland cancer	5.4e-06	0.000111	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CREBBP—salivary gland cancer	5.34e-06	0.00011	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	5.29e-06	0.000109	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—EP300—salivary gland cancer	5.28e-06	0.000109	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTEN—salivary gland cancer	5.18e-06	0.000107	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	5.04e-06	0.000104	CbGpPWpGaD
Methotrexate—ABCC1—Disease—EP300—salivary gland cancer	4.94e-06	0.000102	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PIK3CA—salivary gland cancer	4.92e-06	0.000102	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTEN—salivary gland cancer	4.82e-06	9.94e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PIK3CA—salivary gland cancer	4.72e-06	9.73e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—EP300—salivary gland cancer	4.6e-06	9.48e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTEN—salivary gland cancer	4.34e-06	8.94e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PIK3CA—salivary gland cancer	4.33e-06	8.92e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—EP300—salivary gland cancer	4.14e-06	8.53e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTEN—salivary gland cancer	4.12e-06	8.5e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PIK3CA—salivary gland cancer	4.1e-06	8.45e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TP53—salivary gland cancer	3.96e-06	8.17e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—EP300—salivary gland cancer	3.93e-06	8.11e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PIK3CA—salivary gland cancer	3.9e-06	8.05e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTEN—salivary gland cancer	3.82e-06	7.87e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—HRAS—salivary gland cancer	3.79e-06	7.82e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	3.73e-06	7.69e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PIK3CA—salivary gland cancer	3.65e-06	7.53e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—EP300—salivary gland cancer	3.64e-06	7.51e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PIK3CA—salivary gland cancer	3.4e-06	7.01e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HRAS—salivary gland cancer	3.38e-06	6.97e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CREBBP—salivary gland cancer	3.3e-06	6.8e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PIK3CA—salivary gland cancer	3.06e-06	6.31e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PIK3CA—salivary gland cancer	2.91e-06	6e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CREBBP—salivary gland cancer	2.89e-06	5.96e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PIK3CA—salivary gland cancer	2.69e-06	5.55e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTEN—salivary gland cancer	2.35e-06	4.86e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—EP300—salivary gland cancer	2.25e-06	4.63e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTEN—salivary gland cancer	2.06e-06	4.26e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—EP300—salivary gland cancer	1.97e-06	4.06e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PIK3CA—salivary gland cancer	1.66e-06	3.43e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PIK3CA—salivary gland cancer	1.46e-06	3e-05	CbGpPWpGaD
